Spry Therapeutics Private Limited

Spry Therapeutics Private Limited - travel and hospitality in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U85300MH2021PTC359727 Incorporated 29 April 2021 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company travel and hospitality DPIIT Startup
Revenue · FY 2025
₹30.15 Cr
▲ 86% YoY
Net profit · FY 2025
₹2.35 Cr
Net margin 7.8%
EBITDA · FY 2025
₹3.5 Cr
EBITDA margin 11.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
300
Provident fund records
Directors on board
2
As per MCA filings

About Spry Therapeutics Private Limited

Data last updated:

Spry Therapeutics Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Spry Therapeutics Inc. and recognised as a startup by DPIIT. It operates in the wellness and healthcare centers segment of the travel and hospitality sector. It was incorporated on 29 April 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2021PTC359727. Its GSTIN is 27ABGCS0029M1Z6 (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Brijraj Bhuptani and Riyaz Rehman.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18 Sangam B Wing Four Bunglows Haridwar Marg North Mumbai Suburban, Maharashtra, India – 400061.

As per the financials filed for FY 2025, the company reported a revenue of ₹30.15 Cr, a growth of 86% compared to the previous year. For the same year it recorded a net profit of ₹2.35 Cr (net margin 7.8%) and EBITDA of ₹3.5 Cr (EBITDA margin 11.6%). Revenue has grown at a compounded annual rate (CAGR) of 132% over three years.

The company has about 300 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: SPRY. The company has 2 deals on record (2 secondary share transfers); the latest was in September 2021. The company has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 6 overdue payments to 2 micro and small suppliers.

For more details, the company can be reached via its website sprypt.com.

Company details

CIN U85300MH2021PTC359727
Registration Number 359727
Incorporation Date 29 April 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Spry Therapeutics Inc.
DPIIT Recognition Recognised Startup

Recognitions & Rankings of Spry Therapeutics

DPIIT recognised startup Government of India
Startup India

Contact details

Spry Therapeutics Private Limited's registered office is in Mumbai, Maharashtra. Its website is sprypt.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    18 Sangam B Wing Four Bunglows Haridwar Marg North Mumbai Suburban, Maharashtra, India – 400061
  • Industry
    Travel and Hospitality, Wellness & Healthcare Centers

To see the full contact details of Spry Therapeutics Private Limited, buy the company report.

Comprehensive company report
Spry Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Spry Therapeutics operates one associated brand: SPRY. Each brand links to its own profile.

BrandDescriptionWebsite
Cloud-based practice management is provided for physical therapy clinics.sprypt.com

Business activity

The main business activity of Spry Therapeutics is information and communication. In detail, this covers other information & communication service activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
JInformation and communicationJ8Other information & communication service activities

To see the full business activity and turnover split of Spry Therapeutics Private Limited, buy the company report.

Financials of Spry Therapeutics Private Limited

FY 2025 filings available

Spry Therapeutics Private Limited reported revenue of ₹30.15 Cr (up 86% YoY) for FY 2025.

Revenue · FY 2025
₹30.15 Cr ▲ 86%
Net profit · FY 2025
₹2.35 Cr margin 7.8%
EBITDA · FY 2025
₹3.5 Cr margin 11.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 86%
3 years · compounded
▲ 132%
EBITDA CAGR growth
1 year
▲ 97%
3 years · compounded
▲ 123%

Revenue has grown at a compounded annual rate (CAGR) of 132% over three years, including 86% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.5 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.35 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin11.6%
Net Profit Margin7.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Spry Therapeutics Private Limited, buy the company report.

Board of directors of Spry Therapeutics Private Limited

Spry Therapeutics has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Brijraj BhuptaniDirector29 Apr 20215 Years 6 MonthsCurrent
Riyaz RehmanDirector29 Apr 20215 Years 6 MonthsCurrent

Auditor

Spry Therapeutics Private Limited is audited by Manohar Chowdhry & Associates for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Manohar Chowdhry & AssociatesFY 2022001997S

Shareholding

The shareholding of Spry Therapeutics Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Spry Therapeutics Private Limited, buy the company report.

Deals & funding

Spry Therapeutics Private Limited has 2 deals on record (2 secondary share transfers); the latest was in September 2021.

Total deals
2
Secondary share transfers
2

Deals on record (2 of 2)

WhenDealAmountParties
Sep 2021Secondary share transferUndisclosedBuyer: Spry Therapeutics Inc.
Seller: 2 individuals
Aug 2021Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Spry Therapeutics Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 6 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
Medulla Communications Private Limited
Startup Movers Private Limited

To see the full MSME payment records of Spry Therapeutics Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Spry Therapeutics Private Limited has a workforce of 300 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
300
Active EPFO establishments
1
Employee growth
33.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27300
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23

To see the full employee and EPFO history of Spry Therapeutics Private Limited, buy the company report.

GST

Spry Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27ABGCS0029M1Z6MaharashtraActive11 Jun 2021

To see the full GST registrations and return filing status of Spry Therapeutics Private Limited, buy the company report.

Recent activity

Spry Therapeutics Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Brijraj Bhuptani was appointed as Director on 29 Apr 2021.

AGM
Spry Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Spry Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Brijraj Bhuptani was appointed as Director.
Appointed
Riyaz Rehman was appointed as Director.
Incorporation
29 Apr 2021
Spry Therapeutics Private Limited was registered on 29 Apr 2021 with Roc Mumbai I & aged 5 years 6 months as per MCA records.

News

PT platform SPRY secures $15M
10 Oct 2024 · Expresshealthcare
Spry raises $7 Mn in fresh round
22 Jun 2022 · Entrackr

Frequently asked questions

Spry Therapeutics is an active private limited company based in Mumbai, Maharashtra, India. The company works in wellness and healthcare centers, within the travel and hospitality industry. It was incorporated on 29 April 2021 (5+ years old) and is registered under CIN U85300MH2021PTC359727.

Spry Therapeutics has 2 current directors:

The latest financial statements of Spry Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Spry Therapeutics is 27ABGCS0029M1Z6, registered in Maharashtra.

The CIN (Corporate Identification Number) of Spry Therapeutics is U85300MH2021PTC359727. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Spry Therapeutics was incorporated on 29 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

Spry Therapeutics has 2 deals on record (2 secondary share transfers); the latest was in September 2021.

Brijraj Bhuptani was appointed as Director on 29 Apr 2021. Riyaz Rehman was appointed as Director on 29 Apr 2021.

Yes, Spry Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Spry Therapeutics has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 6 overdue payments to 2 micro and small suppliers. The latest return was filed on 30 Aug 2023.

Spry Therapeutics can be reached through the website sprypt.com. Its registered office is in Mumbai, Maharashtra, India.